CGEM vs KEYS · $830.3M cap vs P/E 57, rev $4.98B
Cullinan Oncology LLC (CGEM) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
CGEM currently screens at market cap $830.3M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the CGEM and KEYS stock pages for the full models.
Not investment advice.